Search results
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
US News & World Report· 2 hours agoFood and Drug Administration announced Thursday. It's a turnaround for the agency: The new recommendation follows an FDA advisory panel vote last week that ...
FDA Advisory Committee finds efficiency of donanemab for Alzheimer's treatment - WNKY News 40...
WNKY· 2 days agoA drug is showing promising results for treating early Alzheimer’s disease, and the Alzheimer’s...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 22 hours agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
FDA Advisory Committee voted against MDMA therapy, what's next?
Task & Purpose· 7 days agoThe committee called into question the efficacy of the research presented to the FDA and claimed it...
FDA advisory panel recommends new Alzheimer's drug after scrutiny
United Press International via Yahoo News· 3 days agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News· 1 day agoA U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic...
AFA responds to approval of Alzheimer’s Drug by FDA Advisory Committee
KTVF Fairbanks· 2 days agoThe U.S. Food and Drug Administration (FDA) Advisory Committee, has approved the Alzheimer’s drug, donanemab. In phase three of the clinical ...
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
Fox News via Yahoo News· 3 days agoAn experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration ...
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 3 days agoThe agency will now take the committee’s advice under consideration as it decides whether to approve...
Unanimous Thumbs-Up From FDA Advisors for Alzheimer's Drug
MedPage Today· 4 days agoAn FDA advisory committee on Monday unanimously supported the investigational drug donanemab for...